Literature DB >> 32415576

Innate immunity orchestrates the mobilization and homing of hematopoietic stem/progenitor cells by engaging purinergic signaling-an update.

Mariusz Z Ratajczak1,2, Mateusz Adamiak3, Kamila Bujko4, Arjun Thapa4, Valentina Pensato4, Magda Kucia4,3, Janina Ratajczak4, Henning Ulrich5.   

Abstract

Bone marrow (BM) as an active hematopoietic organ is highly sensitive to changes in body microenvironments and responds to external physical stimuli from the surrounding environment. In particular, BM tissue responds to several cues related to infections, strenuous exercise, tissue/organ damage, circadian rhythms, and physical challenges such as irradiation. These multiple stimuli affect BM cells to a large degree through a coordinated response of the innate immunity network as an important guardian for maintaining homeostasis of the body. In this review, we will foc++us on the role of purinergic signaling and innate immunity in the trafficking of hematopoietic stem/progenitor cells (HSPCs) during their egression from the BM into peripheral blood (PB), as seen along pharmacological mobilization, and in the process of homing and subsequent engraftment into BM after hematopoietic transplantation. Innate immunity mediates these processes by engaging, in addition to certain peptide-based factors, other important non-peptide mediators, including bioactive phosphosphingolipids and extracellular nucleotides, as the main topic of this review. Elucidation of these mechanisms will allow development of more efficient stem cell mobilization protocols to harvest the required number of HSPCs for transplantation and to accelerate hematopoietic reconstitution in transplanted patients.

Entities:  

Keywords:  Adenosine; Extracellular ATP; Hematopoietic stem cells; Innate immunity; Purinergic signaling; Stem cell mobilization and homing

Mesh:

Year:  2020        PMID: 32415576      PMCID: PMC7367963          DOI: 10.1007/s11302-020-09698-y

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  105 in total

1.  Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.

Authors:  I G Winkler; A R Pettit; L J Raggatt; R N Jacobsen; C E Forristal; V Barbier; B Nowlan; A Cisterne; L J Bendall; N A Sims; J-P Lévesque
Journal:  Leukemia       Date:  2012-01-23       Impact factor: 11.528

2.  FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Jerzy-Roch Nofer; Martine Bot; Martin Brodde; Paul J Taylor; Paul Salm; Volker Brinkmann; Theo van Berkel; Gerd Assmann; Erik A L Biessen
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

3.  Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.

Authors:  Darja Karpova; Michael P Rettig; Julie Ritchey; Daniel Cancilla; Stephanie Christ; Leah Gehrs; Ezhilarasi Chendamarai; Moses O Evbuomwan; Matthew Holt; Jingzhu Zhang; Grazia Abou-Ezzi; Hamza Celik; Eliza Wiercinska; Wei Yang; Feng Gao; Linda G Eissenberg; Richard F Heier; Stacy D Arnett; Marvin J Meyers; Michael J Prinsen; David W Griggs; Andreas Trumpp; Peter G Ruminski; Dwight M Morrow; Halvard B Bonig; Daniel C Link; John F DiPersio
Journal:  J Clin Invest       Date:  2019-05-14       Impact factor: 14.808

4.  Adenosine A₂A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease.

Authors:  Kyu Lee Han; Stephenie V M Thomas; Sherry M Koontz; Cattlena M Changpriroa; Seung-Kwon Ha; Harry L Malech; Elizabeth M Kang
Journal:  J Immunol       Date:  2012-12-07       Impact factor: 5.422

Review 5.  Extravascular coagulation in hematopoietic stem and progenitor cell regulation.

Authors:  T Son Nguyen; Tsvee Lapidot; Wolfram Ruf
Journal:  Blood       Date:  2018-06-04       Impact factor: 22.113

Review 6.  Hematopoietic stem cell mobilization: updated conceptual renditions.

Authors:  H Bonig; T Papayannopoulou
Journal:  Leukemia       Date:  2012-09-06       Impact factor: 11.528

7.  Regulation of hematopoietic stem cell activity by inflammation.

Authors:  Laura G Schuettpelz; Daniel C Link
Journal:  Front Immunol       Date:  2013-07-19       Impact factor: 7.561

8.  The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation.

Authors:  W Wu; C H Kim; R Liu; M Kucia; W Marlicz; N Greco; J Ratajczak; M J Laughlin; M Z Ratajczak
Journal:  Leukemia       Date:  2011-09-20       Impact factor: 11.528

9.  Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.

Authors:  Mateusz Adamiak; Sylwia Borkowska; Marcin Wysoczynski; Malwina Suszynska; Magda Kucia; Gregg Rokosh; Ahmed Abdel-Latif; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Oncotarget       Date:  2015-08-07

10.  The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin.

Authors:  Jessica L Feig; Aranzazu Mediero; Carmen Corciulo; Hailing Liu; Jin Zhang; Miguel Perez-Aso; Laura Picard; Tuere Wilder; Bruce Cronstein
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

View more
  7 in total

Review 1.  The circadian regulation of extracellular ATP.

Authors:  Xin Wang; Yu-Ting Dong; Xiu-Ming Hu; Ji-Zhou Zhang; Nan-Rui Shi; Yan-Qin Zuo; Xu Wang
Journal:  Purinergic Signal       Date:  2022-08-08       Impact factor: 3.950

Review 2.  The Nlrp3 inflammasome - the evolving story of its positive and negative effects on hematopoiesis.

Authors:  Mariusz Z Ratajczak; Magdalena Kucia
Journal:  Curr Opin Hematol       Date:  2021-07-01       Impact factor: 3.218

Review 3.  Extracellular Adenosine Triphosphate (eATP) and Its Metabolite, Extracellular Adenosine (eAdo), as Opposing "Yin-Yang" Regulators of Nlrp3 Inflammasome in the Trafficking of Hematopoietic Stem/Progenitor Cells.

Authors:  Mariusz Z Ratajczak; Magda Kucia
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

Review 4.  Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship.

Authors:  Mariusz Z Ratajczak; Magdalena Kucia
Journal:  Leukemia       Date:  2021-12-01       Impact factor: 11.528

Review 5.  Emerging roles of purinergic signaling in anti-cancer therapy resistance.

Authors:  Michele Zanoni; Anna Pegoraro; Elena Adinolfi; Elena De Marchi
Journal:  Front Cell Dev Biol       Date:  2022-09-19

6.  The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking.

Authors:  Mateusz Adamiak; Kamila Bujko; Arjun Thapa; Valentina Pensato; Katarzyna Brzezniakiewicz-Janus; Janina Ratajczak; Daryl L Davies; Henning Ulrich; Magda Kucia; Mariusz Z Ratajczak
Journal:  Leukemia       Date:  2021-07-20       Impact factor: 11.528

Review 7.  Heme Oxygenase 1 (HO-1) as an Inhibitor of Trafficking of Normal and Malignant Hematopoietic Stem Cells - Clinical and Translational Implications.

Authors:  Mariusz Z Ratajczak; Mateusz Adamiak; Janina Ratajczak; Magda Kucia
Journal:  Stem Cell Rev Rep       Date:  2020-11-16       Impact factor: 5.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.